Abstract
Background: The use of non-fluoroscopic electromechanical mapping (NOGA, Biosense Webster) for clinical endocardial mapping and cell-based therapies is increasing. Prior in vivo studies of left ventricular ejection fraction (LVEF) by NOGA have shown only modest accuracy; however, data were compared to 2-dimensional ventriculography, which frequently overestimates ventricular volumes, rather than magnetic resonance imaging (MRI) which is more accurate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
